| 000 | 01873 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250514031905.0 | ||
| 264 | 0 | _c20020621 | |
| 008 | 200206s 0 0 eng d | ||
| 022 | _a0804-4643 | ||
| 024 | 7 |
_a10.1530/eje.0.1460687 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDalla Vestra, Michele | |
| 245 | 0 | 0 |
_aNitric oxide modulation of renal and cardiac hemodynamics in type 2 diabetes. _h[electronic resource] |
| 260 |
_bEuropean journal of endocrinology _cMay 2002 |
||
| 300 |
_a687-94 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAlbuminuria _xetiology |
| 650 | 0 | 4 |
_aCardiac Output _xdrug effects |
| 650 | 0 | 4 |
_aCoronary Circulation _xphysiology |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xphysiopathology |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xphysiopathology |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGlomerular Filtration Rate _xdrug effects |
| 650 | 0 | 4 | _aHemodynamics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xphysiopathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNitric Oxide _xphysiology |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 |
_aRenal Circulation _xphysiology |
| 650 | 0 | 4 |
_aomega-N-Methylarginine _xpharmacology |
| 700 | 1 | _aSacerdoti, David | |
| 700 | 1 | _aBombonato, Giancarlo | |
| 700 | 1 | _aFioretto, Paola | |
| 700 | 1 | _aFinucci, Gianfranco | |
| 700 | 1 | _aSaller, Alois | |
| 700 | 1 | _aSfriso, Andrea | |
| 700 | 1 | _aBruseghin, Marino | |
| 700 | 1 | _aSambataro, Maria | |
| 700 | 1 | _aVelussi, Mario | |
| 700 | 1 | _aBaggio, Bruno | |
| 700 | 1 | _aNosadini, Romano | |
| 700 | 1 | _aCrepaldi, Gaetano | |
| 773 | 0 |
_tEuropean journal of endocrinology _gvol. 146 _gno. 5 _gp. 687-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1530/eje.0.1460687 _zAvailable from publisher's website |
| 999 |
_c11881038 _d11881038 |
||